Tekmira Pharmaceuticals Corporation logo

Tekmira Pharmaceuticals Corporation (3627)

Market Closed
13 Aug, 06:00
JPX JPX
¥
265. 00
0
0%
¥
3.26B Market Cap
- P/E Ratio
20% Div Yield
12,500 Volume
- Eps
¥ 265
Previous Close
Add Transaction
Day Range
262 265
Year Range
243 335
Want to track 3627 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3627 closed today higher at ¥265, an increase of 0% from yesterday's close, completing a monthly decrease of -1.1194% or -¥3. Over the past 12 months, 3627 stock gained 3.9216%.
3627 pays dividends to its shareholders, with the most recent payment made on Feb 26, 2026. The next announced payment will be in In 2 weeks on Aug 28, 2026 for a total of ¥2.
The last earnings report, released on Apr 10, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tekmira Pharmaceuticals Corporation has completed 2 stock splits, with the recent split occurring on Aug 28, 2013.
The company's stock is traded on one exchange.

3627 Chart

Tekmira Pharmaceuticals Corporation (3627) FAQ

What is the stock price today?

The current price is ¥265.00.

On which exchange is it traded?

Tekmira Pharmaceuticals Corporation is listed on JPX.

What is its stock symbol?

The ticker symbol is 3627.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 20%.

What is its market cap?

As of today, the market cap is 3.26B.

Has Tekmira Pharmaceuticals Corporation ever had a stock split?

Tekmira Pharmaceuticals Corporation had 2 splits and the recent split was on Aug 28, 2013.

Tekmira Pharmaceuticals Corporation Profile

Transportation Infrastructure Industry
Industrials Sector
Masashi Ikeda CEO
JPX Exchange
JP3832370005 ISIN
Japan Country
501 Employees
28 Aug 2026 Last Dividend
28 Aug 2013 Last Split
- IPO Date

Overview

Tecmira Holdings Inc., originally formed in 2004 under the name JNS Holdings Inc., underwent a rebranding in October 2023 to better reflect its futuristic orientation towards providing a comprehensive range of digital transformation (DX) solutions. Based in Tokyo, Japan, its operations encapsulate the convergence of hardware, software, and digital content to enhance business efficiency, communication, and customer experience across various sectors. Tecmira Holdings employs cutting-edge technologies in its solutions, leveraging the expansive potentials of connected devices, cloud services, system integration, and SaaS services. The company's strategic focus extends to the optimization of business processes and the forging of advancements in education, health, finance, and entertainment through the deployment of specialized technology platforms such as CharaTech, EdTech, HealthTech, and FinTech.

Products and Services

  • Connected Devices and Application Services: Offers a range of connected devices designed for personal and professional use, complemented by application services that enhance device functionality and user experience.
  • Customer Support and Maintenance: Provides comprehensive customer service including support, repair, and inspection, alongside maintenance and operation support for its products and solutions.
  • System Integration and SaaS Services: Specializes in the integration of systems and the delivery of Software as a Service (SaaS) solutions aimed at boosting business efficiency and enhancing communication channels.
  • Cloud Services: Delivers robust cloud computing services, enabling businesses to leverage scalable resources for storage, processing, and management of data.
  • CharaTech: Develops products, contents, and services enhanced by familiar characters, aiming to add value through brand engagement and interactive experiences.
  • EdTech: Focuses on the production of digital content and the provision of educational services that are compatible with Education DX, aiming to revolutionize the learning experience.
  • HealthTech: Offers health support services designed to promote wellness and preventive care through the integration of technology in health management practices.
  • FinTech: Engages in the development and provision of financial technology solutions, including cashless payment systems, to streamline transactions for retailers and consumers.
  • Content Development and BPO Services: Engages in creating digital content, software, and system development and operations, alongside providing business process outsourcing services for various industry needs.
  • ICT and IoT Product Development: Offers services in information and communication technology and the Internet of Things, encompassing product development, manufacturing, sales, and customer support.
  • Aiwa Product Sales: In charge of planning and sales of aiwa-branded products, focusing on quality and technological advancement.
  • Digital Content Planning and Production: Specializes in the planning and production of digital content, catering to diverse media and entertainment needs.
  • Mold Production and Plastic Injection Molding: Provides industry-specific services such as mold production and plastic injection molding, catering to manufacturing requirements.

Contact Information

Address: Sumitomo Fudosan Kanda Bldg.II
Phone: 81 3 6838 8800